HHS Recovery Act Recipient Reporting Readiness Tool
Step 3. Select A Grant Award
Review the list of awards and select the Award Title link to see the required reporting data.
| DUNS Number | Award Number | Award Title | Agency | Fiscal Year | Issue Date | Funding Amount |
| 046705849 | 3R01HL079275-05S1 | K+ CHANNEL TRAFFICKING AND MODULATION BY MINK AND MIRP1 | NIH | 2009 | 07-15-2009 | $ 147,263 |
| 046705849 | 3R01HL079275-05S2 | K+ CHANNEL TRAFFICKING AND MODULATION BY MINK AND MIRP1 | NIH | 2009 | 07-16-2009 | $ 0 |
| 060217502 | 1R01AI059228-01A2 | VACCINATION AGAINST RSV WITH CAPSID-MODIFIED AD VECTORS | NIH | 2009 | 05-19-2009 | $ 422,291 |
| 060217502 | 1R01AI072149-01A2 | CROHN'S DISEASE-ASSOCIATED NOD2 MUTANTS | NIH | 2009 | 09-21-2009 | $ 422,500 |
| 060217502 | 1R01AI075092-01A1 | MYCOBACTERIAL SIDEROPHORES: ASSEMBLY, ASSEMBLY INHIBITION, AND ROLE IN VIRULENCE | NIH | 2009 | 05-05-2009 | $ 344,724 |
| 060217502 | 1R01AI076335-01 | DESIGN OF PEPTIDE ENTRY INHIBITORS AND DELIVERY SYSTEMS TO TARGET EMERGING HENIPA | NIH | 2009 | 09-18-2009 | $ 772,511 |
| 060217502 | 1R01AI080754-01A1 | THE PLASMODIUM 2TM AND PHIST PROTEIN FAMILIES | NIH | 2009 | 07-14-2009 | $ 413,951 |
| 060217502 | 1R01CA133008-01A2 | PTEN DEFICIENCY AND TUMOR DEVELOPMENT | NIH | 2009 | 05-05-2009 | $ 338,362 |
| 060217502 | 1R01EB009388-01 | REAL-TIME MULTIPHOTON MICROSCOPY OF PERIPROSTATIC TISSUE ARCHITECTURE | NIH | 2009 | 07-14-2009 | $ 413,932 |
| 060217502 | 1R01ES017295-01 | INTERACTIONS FOR PESTICIDES, MITOCHONDRIA AND GENETICS IN PARKINSON'S DISEASE. | NIH | 2009 | 09-21-2009 | $ 481,400 |
| 060217502 | 1R01GM088999-01 | MODULATION OF OXIDATIVE PHOSPHORYLATION BY MITOCHONDRIAL SOLUBLE ADENYLYL CYCLASE | NIH | 2009 | 08-31-2009 | $ 354,900 |
| 060217502 | 1R01HL091101-01 | EICOSANOID REGULATION IN ATHEROSCLEROSIS: INVOLVEMENT OF INDUCIBLE NO SYNTHASE | NIH | 2009 | 06-19-2009 | $ 427,100 |
| 060217502 | 1R01HL093324-01A1 | MACROPHAGE-LIPOPROTEIN INTERACTIONS | NIH | 2009 | 06-03-2009 | $ 422,500 |
| 060217502 | 1R01NS058979-01A2 | GENETIC PREDISPOSITION & PREVENTION OF NEURAL TUBE DEFECTS (NTDS) | NIH | 2009 | 08-03-2009 | $ 1,185,300 |
| 060217502 | 1R01NS066007-01 | FUNCTIONAL LINK BETWEEN INNATE IMMUNITY, OLIGODENDROCYTE DEVELOPMENT, AND MYELINA | NIH | 2009 | 09-28-2009 | $ 295,750 |
| 060217502 | 1R01NS066042-01 | AXONAL DEGENERATION IN LRRK2 PARKINSON?S DISEASE | NIH | 2009 | 09-15-2009 | $ 422,500 |
| 060217502 | 1R03DA027128-01 | AMYGDALA AMPA GLUR2 DELETION AND OPIOID DEPENDENCE | NIH | 2009 | 07-14-2009 | $ 84,500 |
| 060217502 | 1R21AI073926-01A2 | INTEGRASE-DEFECTIVE LENTIVIRAL BASED INFLUENZA VACCINES | NIH | 2009 | 07-14-2009 | $ 262,878 |
| 060217502 | 1R21HD061277-01 | EXPERIMENTAL ENGINEERING OF OVARIAN GRAFTING TO PROMOTE ANGIOGENESIS FOR FERTILIT | NIH | 2009 | 09-22-2009 | $ 207,958 |
| 060217502 | 1R21NS062165-01A2 | ACTIVATORS OF NRF2/ARE PATHWAY AS THERAPEUTIC TARGET FOR PARKINSON'S DISEASE | NIH | 2009 | 05-26-2009 | $ 232,260 |
| 060217502 | 1R21NS065396-01 | MOLECULAR MECHANISMS OF CA2+ RETENTION IN MITOCHONDRIA | NIH | 2009 | 05-13-2009 | $ 253,250 |
| 060217502 | 1R21NS067398-01 | ROLE OF TELOMERASE IN MYELINATION AND REMYELINATION | NIH | 2009 | 09-17-2009 | $ 211,250 |
| 060217502 | 1R56AI080618-01A1 | MYCOBACTERIAL PROTEASOME INHIBITORS | NIH | 2009 | 07-15-2009 | $ 499,329 |
| 060217502 | 1R56AI083219-01 | IMMUNOCHEMOTHERAPY IN VISCERAL LEISHMANIASIS | NIH | 2009 | 06-03-2009 | $ 473,959 |
| 060217502 | 1RC1DA028556-01 | OPTOTFS: GENETICALLY ENCODED LIGHT-ACTIVATED TRANSCRIPTION FACTORS | NIH | 2009 | 09-21-2009 | $ 169,475 |
| 060217502 | 1RC1HL100579-01 | LET-7 MIRNA CONTROL OF HEART DEVELOPMENT | NIH | 2009 | 09-16-2009 | $ 499,998 |
| 060217502 | 1RC1MH088814-01 | MOLECULAR MECHANISMS OF SSRI ACTION IN CHILDHOOD AND ADOLESCENCE | NIH | 2009 | 09-23-2009 | $ 500,000 |
| 060217502 | 1RC1MH089690-01 | DERIVATION OF CEREBRAL CORTICAL GABAERGIC INTERNEURONS FROM HUMAN IPS CELLS | NIH | 2009 | 09-29-2009 | $ 500,002 |
| 060217502 | 1RC2AG036502-01 | IMAGING NEUROINFLAMMATION IN ALZHEIMER'S DISEASE (AD) WITH (11C)ARACHIDONIC ACI | NIH | 2009 | 09-29-2009 | $ 770,255 |
| 060217502 | 1RC2AT005927-01 | BIOMARKERS OF OXIDATIVE STRESS IN PARKINSON'S DISEASE | NIH | 2009 | 09-15-2009 | $ 735,348 |
| 060217502 | 1RC2DA028847-01 | ADENOVIRUS-BASED ANTI-COCAINE VACCINE | NIH | 2009 | 09-29-2009 | $ 1,946,312 |
| 060217502 | 1RC2DA028928-01 | COMPARATIVE EFFECTIVENESS OF INTERVENTIONS FOR CHRONIC PAIN MANAGEMENT | NIH | 2009 | 09-30-2009 | $ 1,017,585 |
| 060217502 | 1RC4MH092606-01 | MULTILEVEL PROPENSITY METHOD TO REDUCE BIAS IN COMPARATIVE EFFECTIVENESS RESEARCH | NIH | 2010 | 09-27-2010 | $ 764,113 |
| 060217502 | 1S10RR027305-01 | PURCHASE OF A TRIPLE QUADRUPOLE MASS SPECTROMETRY SYSTEM FOR METABOLITE ANALYSIS | NIH | 2010 | 05-06-2010 | $ 330,724 |
| 060217502 | 1S10RR027699-01 | A JEM 1400 ELECTRON MICROSCOPE FOR A CORE FACILITY | NIH | 2010 | 07-08-2010 | $ 378,170 |
| 060217502 | 1S10RR029663-01 | A MULTIPHOTON MICROSCOPE FOR TRANSLATIONAL AND BASIC BIOMEDICAL RESEARCH | NIH | 2010 | 04-15-2010 | $ 638,318 |
| 060217502 | 2R01AI045463-12 | MODIFIED ENVELOPE GLYCOPROTEINS FOR HIV-1 VACCINE | NIH | 2009 | 06-03-2009 | $ 126,699 |
| 060217502 | 2R01EY007977-19A2 | CENTRAL PROCESSING OF VISUAL INFORMATION | NIH | 2009 | 06-17-2009 | $ 392,961 |
| 060217502 | 2R01HD043997-06A2 | MECHANISMS OF PBX-DIRECTED GENETIC AND TRANSCRIPTIONAL CONTROL OF LIMB DEVELOPMEN | NIH | 2010 | 08-25-2010 | $ 350,001 |
| 060217502 | 2R56AI063142-06A1 | ADENOVIRUS ACTIVATION OF ANTIGEN PRESENTING CELLS THROUGH DNA SENSING MECHANISMS | NIH | 2010 | 07-26-2010 | $ 507,780 |
| 060217502 | 3D43TW000018-22S1 | AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM | NIH | 2009 | 09-01-2009 | $ 172,800 |
| 060217502 | 3D43TW000018-22S2 | AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM | NIH | 2009 | 09-02-2009 | $ 43,200 |
| 060217502 | 3K01DK063992-05S1 | GENE THERAPY FOR COOLEY'S ANEMIA IN A NEW MOUSE MODEL | NIH | 2010 | 12-07-2009 | $ 54,000 |
| 060217502 | 3KL2RR024997-04S1 | CLINICAL AND TRANSLATIONAL SCIENCE CENTER (KL2) | NIH | 2010 | 09-23-2010 | $ 221,700 |
| 060217502 | 3R01AI072149-01A2S1 | CROHN'S DISEASE-ASSOCIATED NOD2 MUTANTS | NIH | 2010 | 05-24-2010 | $ 11,563 |
| 060217502 | 3R01AI072790-03S1 | FOXP3 REGULATORY NETWORK MRNA PROFILES AND HUMAN RENAL TRANSPLANT OUTCOMES | NIH | 2009 | 09-14-2009 | $ 535,857 |
| 060217502 | 3R01CA120531-03S2 | CDK CONTROL OF MYELOMA PATHOGENESIS | NIH | 2009 | 08-12-2009 | $ 756,831 |
| 060217502 | 3R01DK027847-27S1 | MEMBRANE PROCESSES MEDIATING K SECRETION | NIH | 2009 | 07-13-2009 | $ 10,072 |
| 060217502 | 3R01DK045218-15S1 | UROGENITAL SYSTEM DEVELOPMENT: THE ACQUISITION OF COORDINATED URETER PERISTALSIS | NIH | 2009 | 07-17-2009 | $ 10,072 |
| 060217502 | 3R01DK045218-16S1 | UROGENITAL SYSTEM DEVELOPMENT: THE ACQUISITION OF COORDINATED URETER PERISTALSIS | NIH | 2010 | 08-18-2010 | $ 200,000 |
| 060217502 | 3R01DK052852-11S1 | INSULIN REGULATED MEMBRANE TRAFFICKING | NIH | 2010 | 12-17-2009 | $ 80,258 |
| 060217502 | 3R01DK059659-07S1 | EPITHELIAL NA CHANNELS AND REGULATION OF NA EXCRETION | NIH | 2009 | 09-22-2009 | $ 16,964 |
| 060217502 | 3R01DK060726-07S2 | MAST-CELL RENIN AND LOCAL ANG II FORMATION | NIH | 2009 | 08-14-2009 | $ 150,993 |
| 060217502 | 3R01DK073466-04S1 | SIR2 REGULATION AND CHEMICAL MODULATION | NIH | 2010 | 12-30-2009 | $ 46,865 |
| 060217502 | 3R01DK082723-01S1 | URETERIC BUD PATTERNING | NIH | 2009 | 09-29-2009 | $ 30,305 |
| 060217502 | 3R01DK082723-02S1 | URETERIC BUD PATTERNING | NIH | 2010 | 09-30-2010 | $ 67,769 |
| 060217502 | 3R01EY009314-16S1 | NEURAL COMPUTATIONS IN VISUAL CORTEX | NIH | 2009 | 09-16-2009 | $ 63,561 |
| 060217502 | 3R01EY011307-14S1 | MOLECULAR BASIS OF PROTEIN TRANSPORT IN PHOTORECEPTOR | NIH | 2010 | 01-07-2010 | $ 79,173 |
| 060217502 | 3R01EY012978-09S1 | POPULATION CODING IN THE RETINA | NIH | 2009 | 09-16-2009 | $ 37,936 |
| 060217502 | 3R01GM021342-35S1 | ENERGETICS OF CHANNEL-BILAYER INTERACTIONS | NIH | 2009 | 09-22-2009 | $ 418,500 |
| 060217502 | 3R01GM042482-19S1 | BRCA2 MODEL SYSTEM | NIH | 2010 | 12-04-2009 | $ 99,800 |
| 060217502 | 3R01GM055427-18S1 | BIOSYNTHESIS OF MEMBRANE PROTEIN GLYCOLIPID ANCHORS | NIH | 2009 | 09-30-2009 | $ 197,955 |
| 060217502 | 3R01GM058055-12S1 | SYNAPTIC MECHANISMS OF GENERAL ANESTHETIC ACTION | NIH | 2009 | 09-28-2009 | $ 41,926 |
| 060217502 | 3R01GM062328-08S1 | BICARBONATE REGULATED ADENYLYL CYCLASE | NIH | 2009 | 07-30-2009 | $ 84,177 |
| 060217502 | 3R01GM062631-08S1 | ANALYSIS OF TELOMERASE REVERSE TRANSCRIPTASE | NIH | 2009 | 09-30-2009 | $ 245,543 |
| 060217502 | 3R01GM070820-06A1S1 | THE MOLECULAR REGULATION OF GLI2 IN HEDGEHOG SIGNALING | NIH | 2010 | 04-23-2010 | $ 10,763 |
| 060217502 | 3R01GM077560-04S1 | MECHANISM OF ION CHANNEL MODULATION BY LIGANDS | NIH | 2009 | 09-11-2009 | $ 348,878 |
| 060217502 | 3R01GM079238-04S1 | IMAGING PROTEIN SYNTHESIS ON THE RIBOSOME USING SINGLE-MOLECULE FRET | NIH | 2010 | 04-07-2010 | $ 101,351 |
| 060217502 | 3R01GM084191-01A1S1 | THE RAC-CGMP SIGNALING PATHWAY | NIH | 2009 | 09-30-2009 | $ 84,500 |
| 060217502 | 3R01HD050704-05S1 | BRACHYURY-DOWNSTREAM GENE NETWORKS IN THE NOTOCHORD | NIH | 2010 | 07-07-2010 | $ 163,930 |
| 060217502 | 3R01HL064647-06S1 | FREE BREATHING CARDIAC MRI SEQUENCES | NIH | 2009 | 05-29-2009 | $ 22,835 |
| 060217502 | 3R01HL085592-03S1 | PHARMACOGENOMICS AND ANTIARRHYTHMIC THERAPY: AN IN SILICO INVESTIGATION | NIH | 2009 | 07-15-2009 | $ 200,001 |
| 060217502 | 3R01MH082425-02S1 | EFFECTIVENESS OF A DEPRESSION CARE MANAGEMENT INITIATIVE IN HOME HEALTHCARE | NIH | 2009 | 09-29-2009 | $ 172,655 |
| 060217502 | 3R01RR020115-07S1 | REAL-TIME CONTROL SYSTEM FOR BIOLOGICAL EXPERIMENTS | NIH | 2010 | 09-29-2010 | $ 302,103 |
| 060217502 | 3R21AI078466-02S1 | PRESENTATION OF STRUCTURAL DETERMINANTS OF THE 2F5 NEUTRALIZATION EPITOPE | NIH | 2009 | 08-07-2009 | $ 338,000 |
| 060217502 | 3R21DE018031-02S1 | CLONING OF THE HOL MUTATION | NIH | 2009 | 09-21-2009 | $ 110,808 |
| 060217502 | 3R37DK027083-31S1 | RECEPTOR-MEDIATED ENDOCYTOSIS-MECHANISM AND FUNCTION | NIH | 2010 | 12-08-2009 | $ 91,218 |
| 060217502 | 3R56AI080618-01A1S1 | MYCOBACTERIAL PROTEASOME INHIBITORS | NIH | 2010 | 06-21-2010 | $ 499,576 |
| 060217502 | 3T32GM008539-14S1 | TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGY | NIH | 2009 | 08-03-2009 | $ 157,500 |
| 060217502 | 3T32GM073546-04S1 | PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCES | NIH | 2009 | 08-12-2009 | $ 78,826 |
| 060217502 | 3T32GM083937-01A1S1 | TRI-INSTITUTIONAL TRAINING PROGRAM IN COMPUTATIONAL BIOLOGY & MEDICINE | NIH | 2009 | 07-10-2009 | $ 261,084 |
| 060217502 | 3U01AI069419-04S1 | CORNELL CLINICAL TRIALS UNIT | NIH | 2010 | 09-27-2010 | $ 180,651 |
| 060217502 | 3U2RTW006901-05S1 | HAITI AIDS RESEARCH TRAINING: MODELS TO IMPLEMENTATION | NIH | 2009 | 09-02-2009 | $ 20,000 |
| 060217502 | 3UL1RR024996-03S1 | CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1) | NIH | 2009 | 09-24-2009 | $ 392,929 |
| 060217502 | 3UL1RR024996-03S2 | CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1) | NIH | 2009 | 09-28-2009 | $ 574,232 |
| 060217502 | 3UL1RR024996-03S3 | CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1) | NIH | 2009 | 09-29-2009 | $ 594,218 |
| 060217502 | 3UL1RR024996-04S1 | CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1) | NIH | 2010 | 09-23-2010 | $ 152,945 |
| 060217502 | 5R01AI045463-13 | MODIFIED ENVELOPE GLYCOPROTEINS FOR HIV-1 VACCINE | NIH | 2010 | 05-05-2010 | $ 126,699 |
| 060217502 | 5R01AI059228-02 | VACCINATION AGAINST RSV WITH CAPSID-MODIFIED AD VECTORS | NIH | 2010 | 05-26-2010 | $ 422,500 |
| 060217502 | 5R01AI072149-02 | CROHN'S DISEASE-ASSOCIATED NOD2 MUTANTS | NIH | 2010 | 08-16-2010 | $ 422,500 |
| 060217502 | 5R01AI076335-02 | DESIGN OF PEPTIDE ENTRY INHIBITORS AND DELIVERY SYSTEMS TO TARGET EMERGING HENIPA | NIH | 2010 | 08-16-2010 | $ 755,261 |
| 060217502 | 5R01AI080754-02 | THE PLASMODIUM 2TM AND PHIST PROTEIN FAMILIES | NIH | 2010 | 06-23-2010 | $ 413,530 |
| 060217502 | 5R01CA133008-02 | PTEN DEFICIENCY AND TUMOR DEVELOPMENT | NIH | 2010 | 08-10-2010 | $ 344,660 |
| 060217502 | 5R01EB009388-02 | REAL-TIME MULTIPHOTON MICROSCOPY OF PERIPROSTATIC TISSUE ARCHITECTURE | NIH | 2010 | 07-15-2010 | $ 437,203 |
| 060217502 | 5R01ES017295-02 | INTERACTIONS FOR PESTICIDES, MITOCHONDRIA AND GENETICS IN PARKINSON'S DISEASE. | NIH | 2010 | 07-01-2010 | $ 422,500 |
| 060217502 | 5R01EY007977-20 | CENTRAL PROCESSING OF VISUAL INFORMATION | NIH | 2010 | 07-02-2010 | $ 400,852 |
| 060217502 | 5R01GM088999-02 | MODULATION OF OXIDATIVE PHOSPHORYLATION BY MITOCHONDRIAL SOLUBLE ADENYLYL CYCLASE | NIH | 2010 | 08-24-2010 | $ 354,900 |
| 060217502 | 5R01HL091101-02 | EICOSANOID REGULATION IN ATHEROSCLEROSIS: INVOLVEMENT OF INDUCIBLE NO SYNTHASE | NIH | 2010 | 08-03-2010 | $ 430,964 |
| 060217502 | 5R01HL093324-02 | MACROPHAGE-LIPOPROTEIN INTERACTIONS | NIH | 2010 | 06-15-2010 | $ 422,500 |
| 060217502 | 5R01NS058979-02 | GENETIC PREDISPOSITION & PREVENTION OF NEURAL TUBE DEFECTS (NTDS) | NIH | 2010 | 07-27-2010 | $ 1,181,035 |
| 060217502 | 5R01NS066007-02 | FUNCTIONAL LINK BETWEEN INNATE IMMUNITY, OLIGODENDROCYTE DEVELOPMENT, AND MYELINA | NIH | 2010 | 08-31-2010 | $ 295,750 |
| 060217502 | 5R01NS066042-02 | AXONAL DEGENERATION IN LRRK2 PARKINSON?S DISEASE | NIH | 2010 | 09-13-2010 | $ 30,138 |
| 060217502 | 5R03DA027128-02 | AMYGDALA AMPA GLUR2 DELETION AND OPIOID DEPENDENCE | NIH | 2010 | 07-29-2010 | $ 84,500 |
| 060217502 | 5R21AI073926-02 | INTEGRASE-DEFECTIVE LENTIVIRAL BASED INFLUENZA VACCINES | NIH | 2010 | 06-29-2010 | $ 222,363 |
| 060217502 | 5R21HD061277-02 | EXPERIMENTAL ENGINEERING OF OVARIAN GRAFTING TO PROMOTE ANGIOGENESIS FOR FERTILIT | NIH | 2010 | 08-18-2010 | $ 248,416 |
| 060217502 | 5R21NS062165-02 | ACTIVATORS OF NRF2/ARE PATHWAY AS THERAPEUTIC TARGET FOR PARKINSON'S DISEASE | NIH | 2010 | 06-04-2010 | $ 232,375 |
| 060217502 | 5R21NS065396-02 | MOLECULAR MECHANISMS OF CA2+ RETENTION IN MITOCHONDRIA | NIH | 2010 | 05-17-2010 | $ 169,005 |
| 060217502 | 5R21NS067398-02 | ROLE OF TELOMERASE IN MYELINATION AND REMYELINATION | NIH | 2010 | 08-19-2010 | $ 211,250 |
| 060217502 | 5RC1DA028556-02 | OPTOTFS: GENETICALLY ENCODED LIGHT-ACTIVATED TRANSCRIPTION FACTORS | NIH | 2010 | 07-26-2010 | $ 169,475 |
| 060217502 | 5RC1HL100579-02 | LET-7 MIRNA CONTROL OF HEART DEVELOPMENT | NIH | 2010 | 08-27-2010 | $ 497,446 |
| 060217502 | 5RC1MH088814-02 | MOLECULAR MECHANISMS OF SSRI ACTION IN CHILDHOOD AND ADOLESCENCE | NIH | 2010 | 08-14-2010 | $ 500,000 |
| 060217502 | 5RC1MH089690-02 | DERIVATION OF CEREBRAL CORTICAL GABAERGIC INTERNEURONS FROM HUMAN IPS CELLS | NIH | 2010 | 07-29-2010 | $ 499,211 |
| 060217502 | 5RC2AG036502-02 | IMAGING NEUROINFLAMMATION IN ALZHEIMER'S DISEASE (AD) WITH (11C)ARACHIDONIC ACI | NIH | 2010 | 08-18-2010 | $ 886,509 |
| 060217502 | 5RC2AT005927-02 | BIOMARKERS OF OXIDATIVE STRESS IN PARKINSON'S DISEASE | NIH | 2010 | 08-23-2010 | $ 718,001 |
| 060217502 | 5RC2DA028847-02 | ADENOVIRUS-BASED ANTI-COCAINE VACCINE | NIH | 2010 | 08-19-2010 | $ 1,894,063 |
| 060217502 | 5RC2DA028928-02 | COMPARATIVE EFFECTIVENESS OF INTERVENTIONS FOR CHRONIC PAIN MANAGEMENT | NIH | 2010 | 08-04-2010 | $ 963,776 |
| 060217502 | R01HL085592-3-002 | PHARMACOGENOMICS AND ANTIARRHYTHMIC THERAPY: AN IN SILICO INVESTIGATION | NIH | 2010 | 03-24-2010 | $- 200,001 |
| 060217502 | RC1ES018479-3-000 | INCREASING CAPACITY AND PUBLIC TRUST: A STRATEGY FOR BUILDING EFFECTIVE SUSTAINAB | NIH | 2012 | 12-30-2011 | $ 108,890 |
| 060217502 | T0AHP15784 | ARRA - SCHOLARSHIPS FOR DISADVANTAGED STUDENTS | HRSA | 2009 | 09-03-2009 | $ 36,215 |
| 060217502 | T0AHP18353 | ARRA - SCHOLARSHIPS FOR DISADVANTAGED STUDENTS | HRSA | 2010 | 06-14-2010 | $ 36,499 |
To continue, click on the Award Title in the list above to obtain detailed data about a specific Award.
The Award Detail screen should display with the data for that award that is available for reporting to FederalReporting.gov.
DISCLAIMER
The data contained in the HHS Recipient Readiness Tool reflects the best available data for HHS grant programs that are subject to Recovery Act Recipient Reporting. Please note that according to OMB supplemental guidance recipients are not required to report on awards less than $25,000 on FederalReporting.gov. For a list of programs that must be reported to FederalReporting.gov please visit Appendix 1 of the June 22nd OMB guidance. For additional questions or concerns on reporting requirements for your award please contact your grants management specialist.
Data are refreshed every 24 hours. Awards issued near the end of the reporting period may not be available for 72 hours pending the timeliness of HHS Agency data transmission. If you are unable to locate your data please contact your grants management specialist.
